Chief Medical Officer

Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025

Spyre Therapeutics announces poster presentations at UEGW 2025

Spyre Therapeutics initiated with bullish view at Deutsche Bank, here's why

This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Medical Science Liaison, Medical Affairs

Spyre Therapeutics is a clinical-stage biotechnology company focusing on innovative treatments for inflammatory bowel disease and other immune-mediated diseases. The Medical Science Liaison will engage with Thought Leaders and study investigators to enhance patient health outcomes, providing strategic medical leadership and support for product development and clinical research.

Sign up with Google

Sign in with Google